Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Pigment Cell & Melanoma Research|April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progressionGeorgina V Long, James S Wilmott, Lauren E Haydu, et al.
Molecular Cancer Therapeutics|September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicineJames S Wilmott, Varsha Tembe, Julie R Howle, et al.
Cancer Research|July 10, 2007
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutantsNiccolò Bolli, Ildo Nicoletti, M Felicetta De Marco, et al.
The American Journal of Pathology|July 11, 2009
Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cellsGuoping Zheng, James Guy Lyons, Thian Kui Tan, et al.
Pigment Cell & Melanoma Research|December 11, 2014
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisVarsha Tembe, Sarah-Jane Schramm, Mitchell S Stark, et al.
NPJ Digital Medicine|July 5, 2022
Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicineKevin Y X Wang, Gulietta M Pupo, Varsha Tembe, et al.
The Journal of Biological Chemistry|February 4, 2015
The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium releaseSerena C Hedgepeth, M Iveth Garcia, Larry E Wagner, et al.
Molecular Cancer Therapeutics|March 3, 2012
A high-throughput panel for identifying clinically relevant mutation profiles in melanomaKen Dutton-Regester, Darryl Irwin, Priscilla Hunt, et al.
Human Molecular Genetics|November 1, 2016
The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerKristie-Ann Dickson, Alexander J Cole, Anthony J Gill, et al.
Breast Cancer Research : BCR|November 27, 2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock, Amanda B Spurdle, Myth T S Mok, et al.
Pageof 8